Literature DB >> 22670585

Prevalence of left ventricular hypertrophy and determinants of left ventricular mass in obese women.

Guido Salvetti1, Andrea Pucci, Paola Fierabracci, Giovanni Ceccarini, Caterina Palagi, Maria Grazia Delle Donne, Vitantonio Di Bello, Paolo Piaggi, Paolo Vitti, Antonio Salvetti, Aldo Pinchera, Ferruccio Santini.   

Abstract

BACKGROUND: Obesity is frequently associated with left ventricular hypertrophy (LVH), a condition leading to an increased cardiovascular risk. AIM: The objective of this study was to evaluate the prevalence of LVH in a cohort of obese women, with a main focus on the anthropometric and clinical parameters that are associated with an increased left ventricular mass (LVM).
METHODS: The study was performed in 166 obese female patients. LVM was measured by echocardiography. The influence of various parameters on LVM was assessed by multivariate analysis.
RESULTS: The prevalence of LVH was drastically different depending on the type of indexed LVM, being 19.9% when the LVM was indexed for body surface area and 72.3% when indexed for height. Age, duration of obesity, weight, waist-to-hip ratio, pulse pressure and hypertension retained an independent direct correlation with the LVM, explaining 39.6% of the overall LVM variability. Among the parameters of the metabolic syndrome, the increase in blood pressure was the main determinant of increased LVM.
CONCLUSIONS: By using allometric indexation of LVM for height, the results of our study indicate a high prevalence of LVH in a cohort of obese women. Hypertension, pulse pressure, age, duration of obesity, bodyweight and fat distribution, expressed as waist-to-hip ratio, predict 40% of LVM variation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22670585     DOI: 10.2165/11593700-000000000-00000

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  29 in total

1.  Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance.

Authors:  Julio A Chirinos; Patrick Segers; Marc L De Buyzere; Richard A Kronmal; Muhammad W Raja; Dirk De Bacquer; Tom Claessens; Thierry C Gillebert; Martin St John-Sutton; Ernst R Rietzschel
Journal:  Hypertension       Date:  2010-05-10       Impact factor: 10.190

2.  Method errors or unexplained biological information?

Authors:  Giovanni de Simone; Richard B Devereux
Journal:  Hypertension       Date:  2010-11-01       Impact factor: 10.190

Review 3.  Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons.

Authors:  Rik P Bogers; Wanda J E Bemelmans; Rudolf T Hoogenveen; Hendriek C Boshuizen; Mark Woodward; Paul Knekt; Rob M van Dam; Frank B Hu; Tommy L S Visscher; Alessandro Menotti; Roland J Thorpe; Konrad Jamrozik; Susanna Calling; Bjørn Heine Strand; Martin J Shipley
Journal:  Arch Intern Med       Date:  2007-09-10

4.  Menopause does not affect blood pressure and risk profile, and menopausal women do not become similar to men.

Authors:  Edoardo Casiglia; Valérie Tikhonoff; Sandro Caffi; Anna Bascelli; Laura Schiavon; Federica Guidotti; Mario Saugo; Martina Giacomazzo; Bortolo Martini; Alberto Mazza; Daniele D'este; Achille C Pessina
Journal:  J Hypertens       Date:  2008-10       Impact factor: 4.844

5.  Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Leonelo Bautista; Maria Grazia Franzosi; Patrick Commerford; Chim C Lang; Zvonko Rumboldt; Churchill L Onen; Liu Lisheng; Supachai Tanomsup; Paul Wangai; Fahad Razak; Arya M Sharma; Sonia S Anand
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

6.  Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss.

Authors:  M A Alpert; C R Lambert; H Panayiotou; B E Terry; M V Cohen; C V Massey; M W Hashimi; V Mukerji
Journal:  Am J Cardiol       Date:  1995-12-01       Impact factor: 2.778

7.  Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the Strong Heart Study.

Authors:  G de Simone; R B Devereux; M Chinali; M J Roman; E T Lee; H E Resnick; B V Howard
Journal:  Nutr Metab Cardiovasc Dis       Date:  2008-07-31       Impact factor: 4.222

8.  Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study.

Authors:  Martin K Rutter; Helen Parise; Emelia J Benjamin; Daniel Levy; Martin G Larson; James B Meigs; Richard W Nesto; Peter W F Wilson; Ramachandran S Vasan
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

9.  Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

Authors:  Peter W F Wilson; Ralph B D'Agostino; Lisa Sullivan; Helen Parise; William B Kannel
Journal:  Arch Intern Med       Date:  2002-09-09

10.  Prognostic significance of left ventricular mass change during treatment of hypertension.

Authors:  Richard B Devereux; Kristian Wachtell; Eva Gerdts; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Jens Rokkedal; Katherine Harris; Peter Aurup; Björn Dahlöf
Journal:  JAMA       Date:  2004-11-17       Impact factor: 56.272

View more
  6 in total

1.  Obesity and hypertension in cardiac hypertrophy: two sides of the same coin?

Authors:  Riccardo Sarzani; Federico Guerra
Journal:  High Blood Press Cardiovasc Prev       Date:  2012-03-01

2.  Prevalence and Clinical Correlates of Left Ventricular Hypertrophy in Black Africans.

Authors:  Marcelo Perim Baldo; Mauer A Gonçalves; Daniel P Capingana; Pedro Magalhães; Amilcar B Tomé da Silva; José Geraldo Mill
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-06-28

3.  Prevalence and determinants of left ventricular hypertrophy in hypertensive patients at a primary care clinic.

Authors:  Sm Ching; Yc Chia; Wa Wan Azman
Journal:  Malays Fam Physician       Date:  2012-08-31

4.  Gallic Acid Reduces Blood Pressure and Attenuates Oxidative Stress and Cardiac Hypertrophy in Spontaneously Hypertensive Rats.

Authors:  Li Jin; Zhe Hao Piao; Simei Sun; Bin Liu; Gwi Ran Kim; Young Mi Seok; Ming Quan Lin; Yuhee Ryu; Sin Young Choi; Hae Jin Kee; Myung Ho Jeong
Journal:  Sci Rep       Date:  2017-11-15       Impact factor: 4.379

5.  Left ventricular mass formulae and prevalence rates of echocardiographic left ventricular hypertrophy in nigerians with essential hypertension.

Authors:  Ebenezer Adekunle Ajayi; Ajayi Ebenezer Adekunle; Iyiade Adeseye Ajayi; Ajayi Iyiade Adeseye; Tolulope Adebayo Oyedeji; Oyedeji Tolulope Adebayo; Adekunle Olatayo Adeoti; Adeoti Adekunle Olatayo; Olusola Joseph Omotoye; Omotoye Olusola Joseph; Rasaaq Ayodele Adebayo; Adebayo Rasaaq Ayodele
Journal:  N Am J Med Sci       Date:  2013-05

Review 6.  Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure.

Authors:  Mark F McCarty
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.